Iris Acquisition II Targets $150M IPO for SPAC Deal

TL;DR

**Avoid this SPAC; the founder share structure creates massive dilution risk and misaligned incentives for public shareholders.**

AI Summary

Iris Acquisition Corp II (IRAB-UN) filed an S-1/A to offer 15,000,000 units at $10.00 each, aiming to raise $150,000,000 for a business combination. Each unit comprises one Class A ordinary share and one-half of one redeemable warrant. The company is a blank check company with a generalist investment approach, seeking a high-quality, mid-market company for accelerated growth. The sponsor, Iris Acquisition Holdings II LLC, purchased 5,750,000 Class B ordinary shares for $25,000, or $0.00435 per share, and will purchase 251,000 private placement units for $2,510,000. Cohen & Company Capital Markets will purchase 150,000 private placement units for $1,500,000. The company will repay up to $300,000 in loans to its sponsor and pay a $20,000 monthly administrative fee. Public shareholders can redeem shares at $10.00 per share upon business combination completion, with no minimum net tangible asset condition. The company has 24 months to complete an initial business combination, or public shares will be redeemed at the trust account value.

Why It Matters

This S-1/A filing signals Iris Acquisition Corp II's intent to raise $150 million, providing a new SPAC vehicle for a private company to go public. For investors, it represents an opportunity to participate in a blank-check company targeting a mid-market acquisition, but also carries the inherent risks of SPACs, including potential dilution and management conflicts of interest. Employees and customers of a future target company could see significant changes post-merger. In the competitive SPAC market, Iris Acquisition II's generalist approach and Dubai-based management team will need to differentiate itself to attract a compelling target.

Risk Assessment

Risk Level: high — The risk level is high due to significant potential dilution from founder shares purchased at $0.00435 per share compared to the public offering price of $10.00 per unit. This creates a strong incentive for the sponsor and management to complete any business combination, even if it's unprofitable for public shareholders, as they stand to make a 'substantial profit' on their initial $25,000 investment. Additionally, the company has 24 months to complete a deal, and if unsuccessful, founder shares, private placement shares, and warrants may expire worthless, further incentivizing a deal.

Analyst Insight

Investors should exercise extreme caution and thoroughly scrutinize any potential business combination target. Given the significant dilution potential from founder shares and warrants, and the inherent conflicts of interest, a 'wait and see' approach is advisable until a definitive merger target is announced and its financials can be independently evaluated.

Financial Highlights

debt To Equity

N/A

revenue

N/A

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

N/A

eps

N/A

gross Margin

N/A

cash Position

$150,000,000

revenue Growth

N/A

Key Numbers

• $150,000,000 — Gross proceeds from IPO (Targeted capital raise from the offering of 15,000,000 units at $10.00 each.)
• 15,000,000 — Units offered (Number of public units being offered in the initial public offering.)
• $10.00 — Offering price per unit (Price at which each unit is offered to the public.)
• 5,750,000 — Founder shares (Number of Class B ordinary shares purchased by the sponsor.)
• $0.00435 — Founder share purchase price per share (Nominal price paid by the sponsor for founder shares, indicating significant potential profit.)
• 24 months — Completion window (Timeframe for the SPAC to consummate an initial business combination.)
• $2,510,000 — Sponsor private placement unit purchase (Aggregate amount Iris Acquisition Holdings II LLC will pay for 251,000 private placement units.)
• $1,500,000 — Underwriter private placement unit purchase (Aggregate amount Cohen & Company Capital Markets will pay for 150,000 private placement units.)
• $20,000 — Monthly administrative fee (Amount paid by the company to its sponsor for administrative services.)
• 20% — Redemption restriction (Maximum percentage of public shares a shareholder group can redeem without prior consent if shareholder approval is sought for a business combination.)

Key Players & Entities

• Iris Acquisition Corp II (company) — Registrant and SPAC
• Iris Acquisition Holdings II LLC (company) — Sponsor of the SPAC
• Cohen & Company Capital Markets (company) — Underwriter and private placement unit purchaser
• Sumit Mehta (person) — Chief Executive Officer of Iris Acquisition Corp II
• Mitchell Nussbaum, Esq. (person) — Counsel from Loeb & Loeb LLP
• Giovanni Caruso, Esq. (person) — Counsel from Loeb & Loeb LLP
• Jose Santos (person) — Counsel from Forbes Hare
• Christopher J. Capuzzi, Esq. (person) — Counsel from Ropes & Gray LLP
• SEC (regulator) — Securities and Exchange Commission
• Nasdaq (regulator) — Stock Market LLC where units will be listed

FAQ

Risk Factors

• Failure to complete an initial business combination [high — operational]: The company has 24 months to complete an initial business combination. If a business combination is not consummated within this timeframe, the company will liquidate, and public shareholders will receive their pro rata portion of the funds held in the trust account. This poses a significant risk to investors if the management team cannot identify and execute a suitable acquisition.
• Dilution from sponsor and underwriter private placements [medium — financial]: The sponsor and underwriters are purchasing private placement units at $10.00 per unit. These units include warrants that can be exercised at $11.50 per share. If these warrants are exercised, it will result in the issuance of additional Class A ordinary shares, potentially diluting existing public shareholders.
• Redemption risk impacting trust account value [medium — financial]: Public shareholders have the right to redeem their shares at $10.00 per share upon completion of a business combination. If a significant portion of shareholders choose to redeem, it could reduce the capital available for the target company and impact the overall success of the business combination.
• Potential regulatory scrutiny of SPACs [medium — regulatory]: The SPAC market has faced increasing regulatory scrutiny. Changes in regulations or enforcement actions could impact the company's ability to complete a business combination or the valuation of the combined entity.
• Sponsor's limited financial commitment [low — operational]: The sponsor purchased founder shares for a nominal amount of $0.00435 per share, totaling $25,000. While they are purchasing private placement units, their initial equity stake is highly leveraged, which could influence their decision-making in a high-risk environment.
• Monthly administrative fee to sponsor [low — operational]: The company will pay its sponsor a $20,000 monthly administrative fee. While not a large sum, this represents an ongoing cost that reduces the capital available for the business combination or operational expenses.

Industry Context

The Special Purpose Acquisition Company (SPAC) market has seen significant activity, offering a faster route to public markets for private companies compared to traditional IPOs. However, the market is also subject to evolving regulatory scrutiny and investor sentiment, which can impact deal flow and valuations. Generalist SPACs like Iris Acquisition Corp II aim to identify high-quality, mid-market companies across various sectors, seeking growth potential through a public listing.

Regulatory Implications

As a SPAC, Iris Acquisition Corp II is subject to SEC regulations governing public offerings and business combinations. The increasing regulatory focus on SPACs, including disclosure requirements and potential changes in accounting standards, could impact the company's operations and the attractiveness of potential targets. Compliance with these regulations is crucial for a successful business combination.

What Investors Should Do

1. Review the sponsor's incentive structure and potential dilution.
2. Assess the management team's ability to identify and execute a suitable business combination within the 24-month timeframe.
3. Understand the redemption rights and their potential impact on the trust account.
4. Monitor regulatory developments in the SPAC market.

Key Dates

• 2025-12-12: Filing of S-1/A Amendment No. 3 — Indicates progress in the registration process for the IPO, providing updated details to potential investors.
• 2025-07-15: Sponsor purchase of Class B ordinary shares — Establishes the sponsor's initial equity stake in the company at a nominal price, highlighting the significant potential upside for the sponsor.

Glossary

SPAC

Special Purpose Acquisition Company. A shell company that is formed to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing company. (Iris Acquisition Corp II is a SPAC, and its primary purpose is to find and merge with a target company.)

Units

A security that combines two or more different types of securities, typically a share of common stock and a warrant. (The IPO is offering units, each consisting of one Class A ordinary share and one-half of a redeemable warrant.)

Redeemable Warrant

A warrant that gives the holder the right, but not the obligation, to purchase a share of common stock at a specified price within a certain timeframe. (These warrants are included in the units and can be exercised after the business combination, potentially diluting shareholders.)

Founder Shares (Class B ordinary shares)

Shares typically held by the SPAC's sponsor, often purchased at a nominal price, which convert into Class A ordinary shares upon a business combination. (The sponsor holds 5,750,000 founder shares, which are subject to anti-dilution adjustments and represent a significant portion of the sponsor's investment.)

Trust Account

An account established by a SPAC to hold the proceeds from its IPO, which are typically invested in U.S. Treasury securities and are used to fund the business combination or returned to shareholders upon liquidation. (The IPO proceeds of $150,000,000 will be placed in a trust account, from which redemptions will be paid.)

Business Combination

The merger, amalgamation, share exchange, asset acquisition, or similar transaction that a SPAC undertakes to combine with an operating company. (Iris Acquisition Corp II has 24 months to complete its initial business combination.)

Private Placement Units

Units purchased by the sponsor and underwriters simultaneously with the IPO, typically at the same unit price as the public offering, but often with different warrant terms or restrictions. (The sponsor and underwriters are purchasing private placement units to align their interests with the public offering.)

Year-Over-Year Comparison

This is an S-1/A filing, which is an amendment to the initial registration statement. As such, it represents an update and refinement of the company's offering details rather than a comparison to a prior year's financial performance. Key updates likely include revised risk factors, updated legal disclosures, and potentially adjustments to the offering structure or use of proceeds based on SEC comments or market conditions.

Key Financial Figures

• $150,000,000 — O COMPLETION, DATED DECEMBER 12, 2025 $150,000,000 Iris Acquisition Corp II 15,000,000
• $10.00 — 5,000,000 units at an offering price of $10.00 each. Each unit consists of one Class A
• $11.50 — ne Class A ordinary share at a price of $11.50 per share, subject to adjustment as des
• $5,000,001 — t tangible asset condition, such as the $5,000,001 net tangible asset requirement. As such
• $2,510,000 — e of $10.00 per private placement unit ($2,510,000 in the aggregate (including if the over
• $1,500,000 — in full) at a price of $10.00 per unit ($1,500,000 in the aggregate (or $1,950,000 if the
• $1,950,000 — r unit ($1,500,000 in the aggregate (or $1,950,000 if the over-allotment is exercised in f
• $300,000 — ring or thereafter, we will repay up to $300,000 in loans made to us by our Sponsor to c
• $20,000 — s, and we will begin paying our Sponsor $20,000 per month (the "Administrative Services
• $2,500,000 — our initial business combination, up to $2,500,000 of such loans may be convertible into p
• $100,000 — shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses
• $0.20 — (1) $ 141,000,000 (1) Includes (A) $0.20 per unit sold in the offering, or 2.0%
• $3,000,000 — the gross proceeds of the offering, or $3,000,000 in the aggregate (or $3,450,000 if the
• $3,450,000 — ing, or $3,000,000 in the aggregate (or $3,450,000 if the underwriters' over-allotment opt
• $0.075 — ion is exercised in full), of which (i) $0.075 per unit sold in the offering, excludin

Filing Documents

• iac2s1a3100825.htm (S-1/A) — 2344KB
• iac2ex1-1.htm (EX-1.1) — 246KB
• iac2ex3-2.htm (EX-3.2) — 253KB
• iac2ex4-1.htm (EX-4.1) — 33KB
• iac2ex4-2.htm (EX-4.2) — 18KB
• iac2ex4-3.htm (EX-4.3) — 33KB
• iac2ex4-4.htm (EX-4.4) — 129KB
• iac2ex5-1.htm (EX-5.1) — 7KB
• iac2ex5-2.htm (EX-5.2) — 75KB
• iac2ex10-1.htm (EX-10.1) — 42KB
• iac2ex10-3.htm (EX-10.3) — 102KB
• iac2ex10-4.htm (EX-10.4) — 51KB
• iac2ex10-7.htm (EX-10.7) — 11KB
• iac2ex10-8.htm (EX-10.8) — 25KB
• iac2ex10-9.htm (EX-10.9) — 48KB
• iac2ex23-1.htm (EX-23.1) — 2KB
• iac2ex99-3.htm (EX-99.3) — 3KB
• iac2ex99-4.htm (EX-99.4) — 3KB
• iac2ex99-5.htm (EX-99.5) — 3KB
• ex3-2_001.jpg (GRAPHIC) — 5KB
• ex5-1_001.jpg (GRAPHIC) — 6KB
• ex5-2_001.jpg (GRAPHIC) — 9KB
• 0001185185-25-002042.txt ( ) — 5441KB
• irab-20251212.xsd (EX-101.SCH) — 9KB
• irab-20251212_def.xml (EX-101.DEF) — 19KB
• irab-20251212_lab.xml (EX-101.LAB) — 124KB
• irab-20251212_pre.xml (EX-101.PRE) — 71KB
• iac2s1a3100825_htm.xml (XML) — 383KB

Underwriting

Underwriting Discount (1) Proceeds, Before Expenses, to us Per Unit $ 10.00 $ 0.60 (1) $ 9.40 Total $ 150,000,000 $ 9,000,000 (1) $ 141,000,000 (1) Includes (A) $0.20 per unit sold in the offering, or 2.0% of the gross proceeds of the offering, or $3,000,000 in the aggregate (or $3,450,000 if the underwriters' over-allotment option is exercised in full), of which (i) $0.075 per unit sold in the offering, excluding any units sold pursuant to the exercise of the underwriter's over-allotment option, or $1,125,000, will be paid to the underwriters in cash; (ii) $0.025 per unit sold in the offering, excluding any units sold pursuant to the exercise of the underwriter's over-allotment option, or up to $375,000 in the aggregate is payable to the underwriters in this offering upon execution of an agreement for an initial business combination, and (iii) $1,500,000 (or $1,950,000 of the underwriters' over-allotment is exercised in full) in the aggregate which will be invested by the underwriter to purchase 150,000 private placement units (or 195,000 private placement units if the over-allotment option is exercised in full) at $10.00 per unit and (B) $0.40 per unit sold in this offering, or 4.0% of the gross proceeds of the offering, or $6,000,000 in the aggregate (or up to $6,900,000 in the aggregate if the underwriters' over-allotment option is exercised in full) payable to the underwriters for deferred underwriting commissions to be deposited in a trust account located in the United States and released to the underwriters only upon the completion of an initial business combination, such fee to be proportionately reduced based on the amount of funds remaining in the trust account after redemptions. See "Underwriting" for additional information regarding underwriting compensation. Of the proceeds we receive from this offering and the sale of the private placement units, $150,000,000 or $172,500,000 if the underwriters' over- allotment option is exercised in

View Full Filing

View this S-1/A filing on SEC EDGAR